ADIPOQ and metabolic dysfunction-associated steatotic liver disease: One explanation for the absence of a NAFLD phenotype may be a compensatory upregulation of adiponectin which activates the AMPK–FOXO-signaling axis and may override detrimental oxidative stress and JNK signaling [41].